Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis

Review of 45 studies including 4 RCTs, 29 cohort studies, and 12 case series found hydroxychloroquine use was not linked to benefit or harm in relation to COVID‐19 mortality, and evidence supporting the effect of other antirheumatic disease therapies is currently inconclusive.

Source:

Arthritis & Rheumatology